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Background: Glial cells are involved in immune and in-
flammatory responses in the central nervous system (CNS). 
Glial cells such as microglia and astrocytes also provide 
structural and functional support for neurons. Migration and 
morphological changes of CNS cells are associated with 
their physiological as well as pathological functions. The se-
creted protein lipocalin-2 (LCN2) has been previously im-
plicated in regulation of diverse cellular processes of glia and 
neurons, including cell migration and morphology. Methods: 
Here, we employed a zebrafish model to analyze the role of 
LCN2 in CNS cell migration and morphology in vivo. In the 
first part of this study, we examined the indirect effect of 
LCN2 on cell migration and morphology of microglia, as-
trocytes, and neurons cultured in vitro. Results: Conditioned 
media collected from LCN2-treated astrocytes augmented 
migration of glia and neurons in the Boyden chamber assay. 
The conditioned media also increased the number of neuro-
nal processes. Next, in order to further understand the role 
o f  L C N 2  i n  t h e  C N S  in vivo, LCN2 was ectopically ex-
pressed in the zebrafish spinal cord. Expression of exoge-
nous LCN2 modulated neuronal cell migration in the spinal 
cord of zebrafish embryos, supporting the role of LCN2 as a 
cell migration regulator in the CNS. Conclusion: Thus, LCN2 
proteins secreted under diverse conditions may play an im-
portant role in CNS immune and inflammatory responses by 
controlling cell migration and morphology.
[Immune Network 2011;11(6):342-347]
INTRODUCTION
Glial cells such as microglia and astrocytes play a supportive 
role in the central nervous system (CNS): for example, micro-
glia  form  a  first-line  of  defense  protecting  the  CNS  from 
pathogens and other harmful conditions; and astrocytes main-
tain homeostasis in the CNS microenvironment by regulating 
neurotransmitter  and  ion  metabolism.  In  addition  to  these 
physiological functions, glial cells also participate in chronic 
neuroinflammation under pathological conditions. Long-last-
ing and excessive activation of glia contributes to neural tis-
s u e  d a m a g e s  i n  n e u r o i n f l a m m a t o r y  a n d  n e u r o d e g e n e r a t i v e  
diseases  such  as  multiple  sclerosis,  Alzheimer’s  disease, 
Parkinson’s disease, and HIV-associated dementia (1-3). Cell 
migration and morphological changes are closely associated 
with chronic activation of glia. Activated glial cells often show 
characteristic changes in migratory and morphological pheno-
types,  which  are  collectively  referred  to  as  reactive  gliosis. 
Molecular mechanisms underlying reactive gliosis has been a 
subject  of  intensive  investigation.
    Lipocalin 2 (LCN2) is a small hydrophobic molecule-bind-
ing  protein,  which  is  also  called  24p3  or  neutrophil  gelati-
nase-associated  lipocalin  (NGAL).  LCN2  plays  an  important 
role in diverse cellular processes, such as cell death/survival 
(4-6), cell migration/invasion (7,8), cell differentiation (9,10), 
iron delivery (4,9,11,12), and insulin resistance (13). Never-
theless, little is known about the role of LCN2 in the CNS. 
Recently, we have reported that the LCN2 protein upregulates Functional Characterization of LCN2 in Zebrafish
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chemokine expression in the CNS (14), and LCN2 promotes 
morphological changes and cell migration in an autocrine or 
paracrine manner (15,16). In this study, we focused on the 
role  of  soluble  mediators  secreted  by  LCN2-activated  as-
trocytes, rather than the direct effects of LCN2 itself. For this 
purpose,  conditioned  media  obtained  from  LCN2-stimulated 
astrocytes were tested for their potential effects on glial and 
neuronal  migration  and  morphology.  In  the  second  half  of 
this study, in vivo role of LCN2 was examined using a zebra-
fish  model.
MATERIALS AND METHODS
Reagents and cells
The recombinant mouse interferon-γ (IFN-γ proteins were 
purchased  from  R&D  Systems;  Minneapolis,  MN).  The  re-
combinant mouse LCN2 protein was prepared, as previously 
described (16). In brief, the recombinant mouse LCN2 protein 
was  expressed  as  a  glutathione  S-transferase  (GST)  fusion 
protein in the BL21 strain of E. coli, which does not synthe-
size  siderophore.  The  protein  was  purified  by  using  gluta-
thione-Sepharose  4B  beads  (GE  Healthcare,  Princeton,  NJ). 
All other chemicals, unless otherwise  stated,  were  obtained 
fr om  Sig m a C he m ic al Co .  (St .  L ou is ,  M O).  Th e m o us e pr i-
mary astrocyte and microglia cultures were prepared from the 
b r a i n s  o f  0 -  t o  3 - d a y - o l d  I C R  m i c e  ( S a m t a k o  C o . ,  O s a n ,  
Korea), as previously described (16). Primary cultures of dis-
sociated cerebral cortical neurons were prepared from embry-
onic day 20 (E20) ICR mice, as described previously (17,18). 
The purity of the glial or neuronal cultures was determined 
by immunocytochemical staining, using antibodies against mi-
croglia-, astrocyte-, or neuron-specific markers. Animals used 
in the current research were acquired and cared for in accord-
ance with guidelines published in  the National  Institutes of 
Health  Guide  for  the  Care  and  Use  of  Laboratory  Animals. 
The study was approved by the  Institutional  Review  Board 
of  the  Kyungpook  National  University  School  of  Medicine.
Preparation of astrocyte-conditioned media
To prepare astrocyte-conditioned media (ACM), primary as-
trocytes prepared from the brains of 0∼3-day-old ICR mice 
w e r e  c u l t u r e d  a t  t h e  d e n s i t y  o f  1 . 5 × 1 0
6  cells  in  100  mm 
plates  in  DMEM,  supplemented  with  10%  FBS  for  24  hr. 
Primary astrocyte cultures were treated with the recombinant 
L C N 2  p r o t e i n  ( 1 0 μg/ml)  or  left  untreated  for  24  hr.  Cells 
w e r e  t h e n  w a s h e d  t w i c e  w i t h  P B S ,  a n d  c u l t u r e d  i n  f r e s h  
DMEM for an additional 24 hr. The ACM was then collected, 
centrifuged at 1,000 rpm for 5 min to remove cell debris, and 
stored  at  −80
oC  until  further  analysis.
In vitro cell migration assays
Cell  migration  was  determined  by  using  a  48-well  Boyden 
chamber (NeuroProbe, Gaithersburg, MD), according to the 
manufacturer’s instructions. ACM was placed into base wells 
separated  from  the  top  wells  by  polyvinylpyrrolidone-free 
polycarbonate  filters  (8μm  p o r e  s i z e ;  2 5 × 8 0  m m ;  N e u r o -
Probe). Cells were harvested by trypsinization, resuspended 
in DMEM, and added to the upper chamber at a density of 
1×10
4 cells/well. Cells were incubated at 37
oC under 5% CO2 
for 48 hr. At the end of the incubation, non-migrating cells 
on the inner side of the membrane were removed with a cot-
ton swab. Migrated cells on the underside of the membrane 
were  fixed  with  methanol  for  10  min  and  stained  with 
Mayer’s Hematoxylin (Dakocytomation, Glostrup, Denmark) 
for 20 min. Photomicrographs of five random fields were tak-
en (Olympus CK2; Tokyo, Japan), and cells were enumerated 
to calculate the average number of cells that had migrated. 
A l l  m i g r a t e d  c e l l s  w e r e  c o u n t e d ,  a n d  t h e  r e s u l t s  w e r e  p r e -
sented  as  the  mean±SD  of  triplicates.
Morphological analysis of neuronal cells
The morphological analysis of neuronal cells was performed 
by  using  fluorescence  microscopy  (Olympus  BX50).  Cells 
were blocked with 1% BSA in PBS-Tween 20 for 10 min and 
incubated in PBS containing 3% BSA and mouse anti-micro-
tubule-associated protein-2 (MAP2) antibody (1:600 dilution; 
Promega). After two washes in PBS-Tween 20, cells were in-
cubated  with  anti-mouse  IgG-fluorescein  isothiocyanate  (FI-
TC)-conjugated  secondary  antibody  (BD  Biosciences,  San 
Jose, CA). Neuronal processes were quantified as previously 
described,  but  with  a  slight  modification  (19).  In  brief,  the 
total number of neuronal process that was longer than one 
cell  body  diameter  was  counted.  The  number  of  neuronal 
process was determined from a minimum of five randomly 
chosen  microscopic  fields  containing  at  least  200  cells.
Zebrafish experiments
Zebrafish embryos were collected from pair mating, raised at 
28.5
oC  in  egg  water,  and  staged  according  to  hours  post-
fertilization (hpf) and morphological criteria as previously de-
scribed (20). Wild-type AB zebrafish line was used for this 
study.  Plasmids  used  in  this  study  were  constructed  by Functional Characterization of LCN2 in Zebrafish
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Figure 2. The effect of LCN2-treated astrocyte conditioned media 
(LCN2-ACM) on the morphology of cortical neuron cells. ACM was 
prepared after the treatment of primary astrocytes with LCN2 (10μg/
ml) or LPS (100 ng/ml) plus IFN-γ (50 units/ml) for 24 hr. The 
addition of LCN2-treated ACM (LCN2-ACM) induced morphological 
changes in primary cortical neuron cells after 24 hr. LPS (100 ng/ml)
plus IFN-γ (50 units/ml)-treated ACM (LPS/IFN-γ-ACM), which was 
used for comparison, also induced similar morphological changes (A).
Primary cortical neuron cells were stained with MAP2 antibody 
(magnification, ×100) followed by the incubation with anti-mouse 
IgG-fluorescein isothiocyanate (FITC)-conjugated secondary antibody 
(scale bar, 25μm). The insets indicate the magnified images. The 
results are one representative of more than three independent 
experiments. The total number of neuronal process was counted for 
each field (B). The results are mean±SD (n=3). *p＜0.05; compared
with the untreated ACM control (CTRL-ACM).
Figure 1. Regulation of glial and neuronal migration by LCN2.
Microglia, astrocytes, or neuronal cells (1×10
4 cells/upper well) were
exposed to control (CTRL) or LCN2 (10μg/ml)-stimulated astrocyte- 
conditioned media (ACM) as indicated. Microglia, astrocytes, or 
neuronal cells placed in the Boyden chambers were incubated at 37
oC
for 48 hr to evaluate cell migration. CTRL-ACM, untreated ACM; 
LCN2-ACM, LCN2-treated ACM (see Materials and Methods for the 
preparation of ACM). The quantification of cell migration was done 
by enumerating the migrated cells as described in the Materials and 
Methods section. The results are mean±SD (n=3). *p＜0.05 com-
pared with CTRL-ACM.
MultiSite Gateway recombination cloning system (Invitrogen). 
To  generate  her4-5'  entry  clone,  her4  promoter  from  the 
pBS-her4 plasmid (21) was ligated into the multiple-cloning 
site  of  p5E-MCS  entry  vector  (22).  The  lcn2-middle  entry 
clone  (16),  EGFP-middle  entry  clone  (pME-EGFP),  EGFP-3' 
(p3E-EGFP) and polyA-3' (p3E-polyA) entry clones (22) were 
used. For the generation of her4:lcn2:egfp construct, LR re-
action was performed with her4-5' entry, lcn2-middle entry, 
and  egfp-3'  entry  clones  according  to  the  Gateway  LR  re-
action manual (Invitrogen). For the generation of  her4:egfp 
c o n s t r u c t ,  L R  r e a c t i o n  w a s  p e r f o r m e d  w i t h  her4-5'  entry, 
egfp-middle (pME-EGFP), and polyA-3' (p3E-polyA) (22) en-
try  clones.  The  final  plasmids  were  prepared  using  the 
EndoFree plasmid kit (Qiagen, Valencia, CA) and injected in-
to one-cell stage embryos at a concentration of 30 ng/μl in 
0.1  M  KCl  solution  containing  0 . 0 5 %  p h e n o l  r e d .  F o r  i m -
munocytochemistry, embryos were fixed in AB Fix (4% paraf-
o r m a l d e h y d e ,  8 %  s u c r o s e ,  1 ×  P B S )  o v e r n i g h t  a t  4
oC,  em-
bedded in 1.5% agarose/30% sucrose, and frozen in 2-methyl 
butane  chilled  by  immersion  in  liquid  nitrogen.  Transverse 
sections (10μm) were  collected by using a cryostat micro-
tome, and sequentially stained with mouse monoclonal anti-
body  against  HuC/D  (1:20  dilution;  Molecular  Probes, 
Eugene, OR) and Alexa Fluor 568-conjugated goat anti-mouse 
IgG  (Molecular  Probes).  The  relative  migration  of  neuronal 
cells of zebrafish embryos was quantified by comparing the 
number of neurons located in the medial position with the 
number of neurons in the lateral margin of the spinal cord.   
Ten  spinal  cord  sections  for  each  embryo  were  quantified. 
Statistical analysis
All data were presented as mean±SD from three or more in-
dependent  experiments,  unless  stated  otherwise.  Statistical 
comparisons between different treatments were done by ei-
t h e r  a  S t u d e n t ’s  t-t e s t  o r  o n e - w a y  A N O V A  w i t h  D u n n e t t ’s 
multiple-comparison  tests  by  using  the  SPSS  version  14.0K 
program  (SPSS  Inc.,  Chicago,  IL).  Differences  with  a  value 
of  p＜0.05  were  considered  to  be  statistically  significant.
RESULTS AND DISCUSSION
We have previously demonstrated that LCN2 upregulates che-
mokine expression in brain astrocytes (14). These results led Functional Characterization of LCN2 in Zebrafish
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Figure 3. Ectopic expression of LCN2 
promotes neuronal migration in the spinal 
cord of zebrafish embryos. The her4:egfp- 
injected control embryo (A) or her4:lcn2: 
egfp-injected embryo (B) was labeled with 
an anti-Hu antibody to detect neurons at 
24 hpf. Arrowheads indicate neurons near 
the  egfp-expressing cells (A) or lcn2:egfp- 
expressing cells (B). Dotted lines indicate 
midline of the spinal cord. All images are
transverse sections of zebrafish spinal cord,
dorsal to top.
Figure 4. The expression of LCN2 attracts developing neurons toward medial position of the spinal cord in zebrafish. The wild-type embryo 
(A) or her4:lcn2:egfp-injected transgenic embryo (B) was labeled with an anti-Hu antibody to detect neurons at 24 hpf. Arrowheads indicate 
neurons near the lcn2:egfp-expressing cells. Dotted lines indicate a lateral margin (a) and medial position (b) of the spinal cord. Numbers indicate 
percentage of neuronal cells in each region. All images are transverse sections of zebrafish spinal cord, dorsal to top. The quantification of 
cell migration was done by enumerating the migrated cells as described in the Materials and Methods section. The results are mean±SD.
us to hypothesize that chemokines secreted by astrocytes may 
regulate cell migration in the CNS. This hypothesis was tested 
by evaluating the effect of LCN2-treated astrocyte conditioned 
media (ACM) on the CNS cell migration. Boyden chamber as-
say  revealed  that  LCN2-treated ACM  (LCN2-ACM)  enhanced 
migration of microglia, astrocytes, and neurons (Fig. 1). It has 
been also previously reported that LCN2 is an autocrine medi-
ator  of  reactive  astrocytosis  (16).  Thus,  LCN2-upregulated Functional Characterization of LCN2 in Zebrafish
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chemokines may also modulate the morphological phenotype 
of  CNS  cells.  Indeed,  LCN2ACM  significantly  increased  the 
number of process in cortical neurons (Fig. 2). The results 
indicate that LCN2 regulates CNS cell migration and morphol-
ogy  through  secretion  of  chemokines  and  other  soluble 
mediators.
    In the next set of experiments, in vivo role of LCN2 was 
examined in  a  zebrafish  model. For  the ectopic expression 
of  lcn2  in  the  zebrafish  CNS  precursor  cells,  we  first  gen-
erated  her4:lcn2:egfp  and  her4:egfp  DNA  constructs,  which 
express  LCN2-EGFP  fusion  protein  and  EGFP  alone,  re-
spectively,  under  the  control  of  her4  promoter  (21).  Each 
DNA  construct  was  injected  into  zebrafish  embryos  at  the 
one-cell stage. Injected embryos were fixed at the 24 hr post 
fertilization (hpf) and labeled with anti-Hu antibody, which 
is a marker for neurons in zebrafish CNS (23,24). In the spinal 
cord of her4:egfp DNA-injected control embryo, EGFP fluo-
rescence  was  detected  in  the  Hu-  non-neuronal  precursor 
cells; Hu
＋ neurons were normally located in the lateral mar-
gin  of  the  spinal  cord  at  the  24  hpf  (Fig.  3A).  However, 
her4:lcn2:egfp DNA-injected embryos showed abnormal local-
ization  of  neurons;  neuronal  cells  near  the  LCN2:EGFP-ex-
pressing cells were located in the more medial position close 
to  the  LCN2:EGFP
＋  cells  compared  to  the  control  embryo 
(Fig.  3B),  indicating  that  LCN2  expression  attracts  neurons. 
LCN2 expression exerted a similar chemotactic effect, when 
the number of Hu
＋ neurons was counted in different regions 
of the spinal cord, medial position versus lateral margin: per-
centage of neuronal cells in the medial position of her4:egfp 
DNA-injected  control  embryo,  5.60±0.78%;  percentage  of 
neuronal  cells  in  the  medial  position  of  her4:lcn2:egfp 
DNA-injected embryos, 11.92±1.39%; the results are mean± 
SD (n=10; p＜0.05) (Fig. 4). These results support that LCN2 
regulates  CNS  cell  migration  in  vivo.
    In this study, we present evidence that LCN2 regulates CNS 
cell migration and morphology possibly by upregulating the 
secretion of chemokines or other soluble mediators. We have 
previously  reported  that  CXCL10  is  one  of  the  chemokines 
produced by astrocytes, and CXCL10 induces CNS cell migra-
tion  and  morphological  changes.  This  was  demonstrated 
mostly using cultured glial cells and neurons. In this study, 
we extended our previous findings to further evaluate the ef-
fects  of  glia-derived  mediators  on  CNS  cell  migration  and 
morphology. Moreover, zebrafish was utilized as an animal 
m o d e l  t o  c o n f i r m  t h e  r e s u l t s   in  vivo.  Our  findings  both  in 
vitro and in vivo settings commonly support that LCN2 modu-
lates CNS cell migration and morphology. These results may 
deepen our understanding of cellular behaviors of brain glial 
cells  and  the  molecular  mechanisms  of  reactive  gliosis.
ACKNOWLEDGEMENTS
This work was supported by Basic Science Research Program 
through the National Research Foundation (NRF) funded by 
the Ministry of Education, Science and Technology (MEST) of 
Korean Government (No. 2011-0028240) and Bio R&D pro-
gram  through  the  NRF  funded  by  the  MEST  (2008-04090).
CONFLICTS OF INTEREST
The  authors  have  no  financial  conflict  of  interest.
REFERENCES
1. Garden  GA,  Möller  T:  Microglia  biology  in  health  and 
disease.  J  Neuroimmune  Pharmacol  1;127-137,  2006.
2. Hanisch UK, Kettenmann H: Microglia: active sensor and 
versatile effector cells in the normal and pathologic brain. 
Nat  Neurosci  10;1387-1394,  2007.
3. Ransohoff  RM,  Perry  VH:  Microglial  physiology:  unique 
stimuli, specialized responses. Annu Rev Immunol 27;119- 
145,  2009.
4. Devireddy LR, Gazin C, Zhu X, Green MR: A cell-surface 
receptor for lipocalin 24p3 selectively mediates apoptosis 
and  iron  uptake.  Cell  123;1293-1305,  2005.
5. Nelson AM, Zhao W, Gilliland KL, Zaenglein AL, Liu W, 
Thiboutot  DM:  Neutrophil  gelatinase-associated  lipocalin 
mediates 13-cis retinoic acid-induced apoptosis of human 
sebaceous gland cells. J Clin Invest 118;1468-1478, 2008.
6. Tong Z, Wu X, Ovcharenko D, Zhu J, Chen CS, Kehrer 
JP: Neutrophil gelatinase-associated lipocalin as a survival 
factor.  Biochem  J  391;441-448,  2005.
7 . Y a n g  J ,  B i e l e n b e r g  D R ,  R o d i g  S J ,  D o i r o n  R ,  C l i f to n  M C , 
Kung AL, Strong RK, Zurakowski D, Moses MA: Lipocalin 
2 promotes breast cancer progression. Proc Natl Acad Sci 
U  S  A  106;3913-3918,  2009.
8. Bauer M, Eickhoff JC, Gould MN, Mundhenke C, Maass N, 
Friedl A: Neutrophil gelatinase-associated lipocalin (NGAL) 
is a predictor of poor prognosis in human primary breast 
cancer.  Breast  Cancer  Res  Treat  108;389-397,  2008.
9. Yang J, Goetz D, Li JY, Wang W, Mori K, Setlik D, Du 
T, Erdjument-Bromage H, Tempst P, Strong R, Barasch J: 
An iron delivery pathway mediated by a lipocalin. Mol Cell 
10;1045-1056,  2002.
10. Bolignano  D,  Donato  V,  Coppolino  G,  Campo  S,  Buemi 
A, Lacquaniti A, Buemi M: Neutrophil gelatinase-associated 
lipocalin  (NGAL)  as  a  marker  of  kidney  damage.  Am  J 
Kidney  Dis  52;595-605,  2008. 
1 1 . F l o  T H ,  S m i t h  K D ,  S a t o  S ,  R o d r i g u e z  D J ,  H o l m e s  M A ,  Functional Characterization of LCN2 in Zebrafish
Ho Kim, et al
347 IMMUNE NETWORK http://www.ksimm.or.kr Volume 11 Number 6 December 2011
Strong RK, Akira S, Aderem A: Lipocalin 2 mediates an in-
nate immune response to bacterial infection by sequestrat-
ing  iron.  Nature  432;917-921,  2004. 
12. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang 
J ,  S c h m i d t - O t t  K M ,  C h e n  X ,  L i  J Y ,  W e i s s  S ,  M i s h r a  J ,  
Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoya-
m a  M ,  K u n i s  C ,  D ' A g a t i  V ,  D e v a r a j a n  P ,  B a r a s c h  J :  
Endocytic  delivery  of  lipocalin-siderophore-iron  complex 
rescues the kidney from ischemia-reperfusion injury. J Clin 
Invest  115;610-621,  2005.
13. Yan QW , Yang Q, Mody N, Graham TE, Hsu CH, Xu Z, 
Houstis NE, Kahn BB, Rosen ED: The adipokine lipocalin 
2 is regulated by obesity and promotes insulin resistance. 
Diabetes  56;2533-2540,  2007.
14. Lee S, Kim JH, Kim JH, Seo JW, Han HS, Lee W H, Mori 
K, Nakao K, Barasch J, Suk K: Lipocalin-2 is a chemokine 
inducer in the central nervous system: role of chemokine 
ligand  10  (CXCL10)  in  lipocalin-2-induced  cell  migration. 
J  Biol  Chem  286;43855-43870,  2011.
15. Lee S, Lee J, Kim S, Park JY, Lee W H, M ori K, Kim SH, 
Kim IK, Suk K: A dual role of lipocalin 2 in the apoptosis 
and deramification of activated microglia. J Immunol 179; 
3231-3241,  2007.
16. Lee  S,  Park  JY,  Lee  WH,  Kim  H,  Park  HC,  Mori  K,  Suk 
K:  Lipocalin-2  is  an  autocrine  mediator  of  reactive  astro-
cytosis.  J  Neurosci  29;234-249,  2009.
17. Enokido Y, Akaneya Y, Niinobe M, Mikoshiba K, Hatanaka 
H: Basic fibroblast growth factor rescues CNS neurons from 
cell death caused by high oxygen atmosphere in culture. 
Brain  Res  599;261-271,  1992.
18. Araki  W,  Yuasa  K,  Takeda  S,  Shirotani  K,  Takahashi  K, 
Tabira  T:  Overexpression  of  presenilin-2  enhances  apop-
totic death of cultured cortical neurons. Ann N Y Acad Sci 
920;241-244,  2000.
19. Chou SY, Weng JY, Lai HL, Liao F, Sun SH, Tu PH, Dickson 
DW, Chern Y: Expanded-polyglutamine huntingtin protein 
suppresses the secretion and production of a chemokine 
(CCL5/RANTES)  by  astrocytes.  J  Neurosci  28;3277-3290, 
2008.
20. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling 
TF: Stages of embryonic development of the zebrafish. Dev 
Dyn  203;253-310,  1995.
21. Yeo SY, Kim M, Kim HS, Huh TL, Chitnis AB: Fluorescent 
protein expression driven by her4 regulatory elements re-
veals the spatiotemporal pattern of Notch signaling in the 
nervous  system  of  zebrafish  embryos.  Dev  Biol  301;555- 
567,  2007.
22. Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME, 
Campbell DS, Parant JM, Yost HJ, Kanki JP, Chien CB: The 
Tol2kit: a multisite gateway-based construction kit for Tol2 
transposon  transgenesis  constructs.  Dev  Dyn  236;3088- 
3099,  2007.
23. Kim CH, Bae YK, Yamanaka Y, Yamashita S, Shimizu T, 
Fujii  R,  Park  HC,  Yeo  SY,  Huh  TL,  Hibi  M,  Hirano  T: 
Overexpression of neurogenin induces ectopic expression 
of  HuC  in  zebrafish.  Neurosci  Lett  239;113-116,  1997.
24. Park HC, Kim CH, Bae YK, Yeo SY, Kim SH, Hong SK, 
Shin  J,  Yoo  KW,  Hibi  M,  Hirano  T,  Miki  N,  Chitnis  AB, 
H u h  T L : A n a ly s is  o f u p s tre a m  e le m e n ts in  th e  H u C  p ro-
m o t e r  l e a d s  t o  t h e  e s t a b l i s h m e n t  o f  t r a n s g e n i c  z e b r a f i s h  
with  fluorescent  neurons.  Dev  Biol  227;279-293,  2000.